arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PULSE BIOSCIENCES, INC.

PLSE
$51.88 ▼ -0.81 (-1.54%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
47 Visible periods
22 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

PULSE BIOSCIENCES, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.6B
Dividend Yield
Revenue Growth None
Op. Margin
ROIC -20.1%
FCF / Share $-0.27
Trailing P/E
Price / Book 36.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

47-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$434.00K
↑ +8.2%
Net Income Profit after all expenses
$-18.58M
↑ +3.1%
FCF / Share Free cash flow per share
$-0.27
↓ -26.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
10
Cash Quality
51

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 12 years · 47 quarters